What is it about?
We analyse the pattern and outcome of investigations for BTD among children and young people in a Scottish NHS Board. We retrospectively analysed the clinical and laboratory data of all children within the Fife area who were screened for BTD between July 2014 and July 2016.
Featured Image
Why is it important?
Biotinidase deficiency (BTD) is an autosomal recessive metabolic disorder characterized by neurodevelopmental and cutaneous disorders. Individuals with BTD have either homozygous or compound heterozygous variants of biotinidase (BT) enzyme.
Perspectives
Read the Original
This page is a summary of: Clinical Indications and Outcome of Biotinidase Deficiency Screening among Children and Youths in a Scottish NHS Region Between 2014 and 2016, January 2017, International Technology and Science Publications,
DOI: 10.31058/j.hr.2017.11005.
You can read the full text:
Resources
Contributors
The following have contributed to this page